Skip to content

My Symptoms - Feasibility Study

My Symptoms - Feasibility Study: Feasibility of Intervention and Evaluation of an eHealth and GP Assisted Programme for Persistent Symptoms in Primary Care for Persistent Symptoms in Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05287087
Enrollment
40
Registered
2022-03-18
Start date
2022-03-31
Completion date
2023-06-30
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Physical Symptoms

Brief summary

The proposed project 'My Symptoms' is part of a large research programme: eHealth and GP-assisted self-help interventions for persistent physical symptoms (eASY). See www.minesymptomer.dk. The research programme is an ambitious and dedicated effort aiming at improvement of functioning and quality of life for individuals with persistent physical symptoms (PPS) and prevention of the development of chronic functional disorders and associated loss of working capacity and high use of health care. At present, access to specialized treatment of PPS is very limited and treatment capacity in general practice is restricted to brief consultations - often with poor opportunity to make a treatment plan for symptoms. In order to improve health care for patients with PPS, the investigators have developed a web-based selfhelp programme for symptoms. As part of the intervention, this programme is prescribed by the patient's general practitioner (GP). The investigators have applied a high degree of user involvement (GPs and patients) in the development process but there is a need to evaluate how the new treatment programme is in fact adopted and how it affects GPs in routine care and patients in daily life. With this study, the investigators wish to take the first step towards a comprehensive and rigorous evaluation. Results from this feasibility study will both qualify a subsequent randomised controlled trial (RCT) in a larger pilot study and provide information for a potential national dissemination.

Detailed description

Drawing on existing evidence about symptoms, functional disorders and eHealth interventions combined with user involvement, the investigators have developed a web-based self-help programme for PPS: My Symptoms. The programme builds on the bio-psycho-socialexistential illness model and enhanced cognitive behavioural theory. Seven treatment modules focus on psychoeducation, lifestyle intervention, self-regulation and graded exercise delivered through text, videos, animations and audio files (see overview of content in table 1). Furthermore, it includes a 1-day course for GPs and a mandatory follow-up appointment between patient and GP at the programme closure. The training course for the GPs will focus on patient identification, positive reinforcement and familiarity with the content of the programme. The programme must be prescribed by GPs and is recommended to use for 6 weeks. The objectives with the present feasibility study are: 1) to test and refine the GP training course, 2) to explore the planned logistics for patient recruitment, 3) to evaluate GP and patient questionnaires, and 4) to evaluate patients' use of the programme and 5) follow-up consultations with their GP. With regard to 2-5, the following questions will be adressed and explored: 1. Which modifications are needed to the predefined procedures for consecutive patient enrolment? 2. What are the results of patient enrolment with respect to recruitment rates and patient characteristics? (Patients are asked and screened consecutively, but how many accept participation and fulfil inclusion criteria? What characterises enrolled patients compared to refusers?) 3. To what extent do patients accept and engage with the baseline research questionnaires? 4. When do included patients engage with the programme after enrolment (delay in time)? 5. How much do included patients interact with the intervention, i.e. how many patients log into the program, which modules and pages are accessed, and how many tools are used? 6. How many patients consult the GP for a follow-up consultation and when does this consultation take place? 7. How many contacts do the patients have to participating practices during their use of the programme? Alongside this part of the feasibility study, the investigators will conduct a separate in-depth qualitative study (field study observations and interviews) on GP and patient interactions with the intervention. A separate protocol has been developed for this part of the feasibility study.

Interventions

BEHAVIORALMy Symptoms 1 (MySt-1)

The patients will get access to an eHealth programme consisting of: 1. A questionnaire including the BDS checklist 2. A brief introductory animation about how to understand symptoms in general 3. Basic information on symptom in general and on six common symptoms: headache, fatigue, dizziness, pain, dyspepsia and abdominal unease. 4. A brief animation about the interaction of body and mind. These four provisions are identical to the first part of the MySt-2.

BEHAVIORALMy Symptoms 2 (MySt-2)

The patients will get access to an eHealth programme consisting of: 1. A questionnaire including the BDS checklist 2. A brief introductory animation about how to understand symptoms in general 3. Basic information on symptom in general and on six common symptoms: headache, fatigue, dizziness, pain, dyspepsia and abdominal unease. 4. A brief animation about the interaction of body and mind. 5. Thorough symptom explanations 6. Physical energy (focus on sleep, diet and activity) 7. Values and choices (focus on meaning and existential issues) 8. Emotional health (focus on emotion regulation) 9. Mental energy (focus on stress regulation and thinking) After 4-6 weeks, the patient will see the GP for a follow-up consultation.

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Masking description

We will inform GPs about the possibility of being assigned to one of two interventions expected to have each their advantages and disadvantages, hence being of equal value to patients. The GPs will know the content of their assignment but will not be informed about the specific content of the other intervention. Enrolled patients will only be informed whether they are to use the programme My Symptoms 1 or My Symptoms 2 accessed via a website. Outcome assessment and data analyses in this feasibility study conducted by the project researchers will not be blinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Listed with participating practice * Giving informed consent to participation in the study * Consulting a GP or GP supervised staff * Multiple symptoms, i.e. 4 or more symptoms within the past 4 weeks, according to the Bodily Distress Syndrome checklist (a validated symptom checklist with 25 items)

Exclusion criteria

* Not consulting for symptoms * Symptoms are due to acute disease * Symptoms must primarily be treated by medicine or surgery * Not eligible due to language or cognitive problems * Patient severely affected by other disease * Other, GP assessment/statement (e.g.: All symptoms are with recent onset and I see no need for intervention at present, I do not believe the patient will benefit the least bit from participation in the eHealth programme at this time) * Patient declines to use the eHealth program despite GP recommendation * Patient has not accessed the programme within 2 weeks from referral from the GP Criteria for stratification: \- Long-term sick leave, i.e. more than 8 weeks, will be a criterion for stratification in order to enable analyses on the target group of patients with PPS without chronicity

Design outcomes

Primary

MeasureTime frame
Number of patients in the target age group visiting the practiceRecruitment (Week 1)
Number of patients refusing participationRecruitment (Week 1)
Number of patients fulfilling the inclusion criteriaRecruitment (Week 1)
Number of patients excluded by the GPs and reasons for thisRecruitment and/or referral consultation (Week 1-3 expectedly)
Number of patients not accepting the invitation for intervention despite consent to participate in the project (drop-outs)Invitation for referral consultation/at referral consultation (Week 1-3 expectedly)
Number of patients who do not log into the programme within 2 weeks from referral or only log into the programme once (drop-outs)2 weeks after referral consultation (Week 4-5 expectedly)

Secondary

MeasureTime frameDescription
Evaluation of GP at referral consultationProgramme login (baseline)6 items
Program expectationsProgramme login (baseline)2 items adapted from the Credibility Expectancy Questionnaire
Quality of lifeProgramme login (baseline), end of treatmentSF-36
Pain self-efficacyProgramme login (baseline), end of treatmentPain Self-Efficacy Questionnaire
SymptomsRecruitment (screening), programme login (baseline), end of treatmentBodily Distress Syndrome checklist
Productivity CostsProgramme login (baseline), end of treatmentProductivity Costs Questionnaire (IMTA)
Health care utilizationProgramme login (baseline), end of treatmentMedical Consumption Questionnaire (IMTA)
Program evaluationEnd of treatment13 items
Global impression of changeEnd of treatment1 item
Illness behaviorProgramme login (baseline), end of treatmentThe Behavioural Responses to Illness Questionnaire
Symptom intensity and interferenceRecruitment (screening), programme login (baseline), end of treatment
Illness perceptionRecruitment (screening), programme login (baseline), end of treatmentIllness Perception Questionnaire
Anxiety and DepressionRecruitment (screening), programme login (baseline), end of treatmentSymptom Checklist (SCL)-13
Health anxietyRecruitment (screening), programme login (baseline), end of treatmentWhiteley-6R
Global healthRecruitment (screening), programme login (baseline), end of treatmentOne item from SF-36

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026